HomeGTBP • NASDAQ
add
GT Biopharma Inc
Previous close
$2.74
Day range
$2.71 - $2.78
Year range
$2.60 - $10.66
Market cap
5.90M USD
Avg Volume
40.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.09M | -15.66% |
Net income | -2.27M | -898.24% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.81M | -50.72% |
Total assets | 9.91M | -50.65% |
Total liabilities | 4.60M | -34.59% |
Total equity | 5.31M | — |
Shares outstanding | 1.42M | — |
Price to book | 0.71 | — |
Return on assets | -64.34% | — |
Return on capital | -120.03% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.27M | -898.24% |
Cash from operations | -4.16M | -43.26% |
Cash from investing | 5.03M | 172.03% |
Cash from financing | — | — |
Net change in cash | 871.00K | 124.01% |
Free cash flow | -3.83M | -56.08% |
About
Founded
1965
Headquarters
Website
Employees
2